Widely used in immunology research as a synthetic toll-like receptor 2 (TLR2) agonist. It mimics bacterial lipopeptides and activates immune cells such as dendritic cells, macrophages, and B cells, leading to cytokine production and enhanced antigen presentation. Commonly employed as a vaccine adjuvant to boost immune responses against co-administered antigens. Also used in studies involving innate immunity, vaccine development, and cancer immunotherapy. Its structure allows for strong immunostimulatory effects with consistent and reproducible activation of TLR2 pathways. Frequently incorporated into experimental models to study inflammatory responses and immune cell signaling.